Pulmonary endarterectomy in a 12-year-old boy with multiple comorbidities
- PMID: 32284848
- PMCID: PMC7119433
- DOI: 10.1177/2045894019886249
Pulmonary endarterectomy in a 12-year-old boy with multiple comorbidities
Abstract
A 10-year-old boy, with multiple comorbidities presented with fever, exertional dyspnea, fatigue and an obliterated brachiocephalic and inferior caval vein. Chronic thromboembolic pulmonary hypertension (CTEPH) was diagnosed. Nadroparine, antibiotics and supplemental oxygen were successfully started. Aged 12 years, supplemental oxygen was permanently needed with progressive exertional dyspnea and fatigue. In the country of residence the patient was considered as inoperable. The right ventricle was severely dilated, hypocontractile and hypertrophic. Mean pulmonary artery pressure (mPAP) was 79 mmHg and cardiac output 2.2 L/min. Pulmonary endarterectomy was uneventful. Four days later, mPAP was 33 mmHg and cardiac output 6.4 L/min. Three months later the boy restarted his education without supplemental oxygen. Six months after surgery right ventricular size and function and mPAP (14 mmHg) were normal. We demonstrated that pulmonary endarterectomy in young aged children is feasible and well-tolerated, even in the presence of severe co-morbidities. CTEPH should be an important diagnostic consideration in symptomatic children with a known hypercoaguable state, a history of thrombo-embolism or venous catheter placement, and/or a diagnosis of pulmonary hypertension. Hesitating to refer children for surgical consideration, or attempting to treat them by medication, only postpones the single potentially curable treatment and may worsen their prognosis.
Keywords: CTEPH: chronic thromboembolic pulmonary hypertension; pediatric; surgery.
© The Author(s) 2019.
Figures
References
-
- Madani M, Mayer E, Fadel E, et al. Pulmonary endarterectomy. Patient selection, technical challenges, and outomes. Ann Am Thorac Soc 2016; 13: S240–S247. - PubMed
-
- Mahmud E, Madani MM, Kim NH, et al. Chronic thromboembolic pulmonary hypertension. Evolving therapeutic approaches for operable and inoperable disease. J Am Coll Cardiol 2018; 71: 2468–2486. - PubMed
-
- Ende-Verhaar YM, Cannegieter SC, Vonk Noordegraaf A, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism: a contemporary view of the published literature. Eur Respir J 2017; 49: 1601792. - PubMed
-
- Arthur Ataam J, Mercier O, Lamrani L, et al. ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2019; 38: 982–996. - PubMed
-
- Mercier O, Arthur Ataam J, Langer NB, et al. Abnormal pulmonary endothelial cells may underlie the enigmatic pathogenesis of chronic thromboembolic pulmonary hypertension. J Heart Lung Transplant 2017; 36: 305–314. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
